SEC Form 4/A · accession 0001179110-15-005250
ALBANY MOLECULAR RESEARCH INC · AMRI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Steven R Hagen
Officer — SVP Manufacturing & Pharmaceut
Period of report
Mar 17, 2015
Accepted (ET)
Mar 19, 2015 · 5:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001065087
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 17, 2015 | M | 3,500 | $8.90 | A | 34,700 | D | |
| Common Stock | Mar 17, 2015 | S | 3,500 | $18.53 | D | 31,200 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $8.90 | Mar 17, 2015 | M | 3,500 | A | — | Mar 8, 2020 | Common Stock | 3,500 | 7,000 | D |
Explanation of responses
- F1100% of grant is time based. Time based grant vests 20% per year on each of the first 5 anniversaries of the date of grant (March 8, 2010). The 3,500 shares being exercised represent a portion of the vested grant.
Remarks
The purpose of this amendment is to correct errors in Tables I and II in the original filing made on March 19, 2015.